Spero Therapeutics Inc (SPRO) — Free Cash Flow Generation Index
Latest as of September 2025:
1.00x
Spero Therapeutics Inc (SPRO) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $17.42 Million represents 1% of operating cash flow ($17.42 Million). Explore SPRO capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$17.42 Million
USD
Operating Cash Flow
$17.42 Million
USD
Capital Expenditures
$0.00
USD
Annual Free Cash Flow Generation for Spero Therapeutics Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Spero Therapeutics Inc. Check how aggressively does Spero Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).